“Trainees at the Ph.D. and postdoctoral level are leaving the academic research track at alarming rates, and disproportionately if they’re members of groups underrepresented in the biomedical sciences,” says Carrie Cameron, Ph.D., associate professor of Behavioral Science.
To understand why this is happening, MD Anderson researchers looked at the role that both formal and informal scientific communication skills play in STEM doctoral...
Surveying the landscape of T cell presence and activity across the lungs of patients treated for localized non-small cell lung cancer, researchers...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon form of ALCL that was first reported in 1996. The U.S....
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of cancer treatment in which surgeons apply heated chemotherapy after surgically removing tumors. This innovative method is used to treat mesothelioma, appendix, colorectal and other types of cancer.
Recently, Brian Badgwell, M.D., professor of Surgical Oncology, used HIPEC in a Phase II clinical trial...
While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the disease...
Immunotherapies have brought the potential for long-term remission and even cures to patients with many cancer types, but the benefits have...
President Donald Trump today announced his intent to appoint Hussein Tawbi, M.D., Ph.D., associate professor and deputy chairman of Melanoma...
Chimeric antigen receptor (CAR) T cells were approved by the FDA to treat relapsed and refractory large B-cell lymphoma in adults in 2017....
Cellular therapies have emerged as an effective new therapy for patients with certain types of cancer, and MD Anderson has played an important...
Researchers from MD Anderson have revealed how glioma cells move and infiltrate the brain, providing a new potential treatment pathway to...